Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16459254rdf:typepubmed:Citationlld:pubmed
pubmed-article:16459254lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:16459254lifeskim:mentionsumls-concept:C0599278lld:lifeskim
pubmed-article:16459254pubmed:issue1lld:pubmed
pubmed-article:16459254pubmed:dateCreated2006-2-6lld:pubmed
pubmed-article:16459254pubmed:abstractTextThe endothelin-A receptor ligand Atrasentan (ABT-627) was radiolabeled by (11)C-methylaton of the desmethyl precursor in phenolate form. In mice, the highest uptake of [(11)C]ABT-627 was in the liver, kidneys and lungs. No significant binding was observed in mouse brain or heart. PET studies in a baboon, however, showed accumulation in the myocardium and lungs with a tissue/blood equilibrium reached at 40 min postinjection. Between 35 and 75 min, the heart/blood and lung/blood ratios were 1.72 and 1.31, respectively. Pretreatment with a 0.39 mg/kg dose of unlabeled ABT-627 inhibited the uptake of the tracer by 53-54% in both the myocardium and lungs at 65 min.lld:pubmed
pubmed-article:16459254pubmed:languageenglld:pubmed
pubmed-article:16459254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:citationSubsetIMlld:pubmed
pubmed-article:16459254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459254pubmed:statusMEDLINElld:pubmed
pubmed-article:16459254pubmed:monthJanlld:pubmed
pubmed-article:16459254pubmed:issn0969-8051lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:RavertHayden...lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:ScheffelUrsul...lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:MathewsWillia...lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:DannalsRobert...lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:SzaboZsoltZlld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:HiltonJohnJlld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:ZoberTamas...lld:pubmed
pubmed-article:16459254pubmed:authorpubmed-author:SleepDarrylDlld:pubmed
pubmed-article:16459254pubmed:issnTypePrintlld:pubmed
pubmed-article:16459254pubmed:volume33lld:pubmed
pubmed-article:16459254pubmed:ownerNLMlld:pubmed
pubmed-article:16459254pubmed:authorsCompleteYlld:pubmed
pubmed-article:16459254pubmed:pagination15-9lld:pubmed
pubmed-article:16459254pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:meshHeadingpubmed-meshheading:16459254...lld:pubmed
pubmed-article:16459254pubmed:year2006lld:pubmed
pubmed-article:16459254pubmed:articleTitleSynthesis and in vivo evaluation of a PET radioligand for imaging the endothelin-A receptor.lld:pubmed
pubmed-article:16459254pubmed:affiliationDepartment of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. bmathews@petscan.nm.jhu.edulld:pubmed
pubmed-article:16459254pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16459254pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16459254pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed